Advanced

Cancer and male reproductive function- the effect on sperm DNA integrity and on birth outcomes in the offspring

Ståhl, Olof LU (2008) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2008:121.
Abstract
Male cancer survivors (MCS) are at risk of suffering from impaired fertility. Male fertility is dependant on sperm DNA quality. The Sperm Chromatin Structure Assay (SCSA) reflects the proportion of sperm with poor DNA, the DNA fragmentation index, DFI. A high DFI indicates reduced in vivo fertility and the need of ICSI (Intracytoplasmic sperm injection) to achieve pregnancy. A concern with ICSI, in which a single spermatozoon is injected into the oocyte, is the risk of transmitting defect DNA to the offspring. For MCS, due to the potential mutagenicity of radiotherapy (RT) and chemotherapy (CT), demonstrated in animal studies, this concern is even more pronounced.

The aims of my thesis were to investigate the impact of cancer... (More)
Male cancer survivors (MCS) are at risk of suffering from impaired fertility. Male fertility is dependant on sperm DNA quality. The Sperm Chromatin Structure Assay (SCSA) reflects the proportion of sperm with poor DNA, the DNA fragmentation index, DFI. A high DFI indicates reduced in vivo fertility and the need of ICSI (Intracytoplasmic sperm injection) to achieve pregnancy. A concern with ICSI, in which a single spermatozoon is injected into the oocyte, is the risk of transmitting defect DNA to the offspring. For MCS, due to the potential mutagenicity of radiotherapy (RT) and chemotherapy (CT), demonstrated in animal studies, this concern is even more pronounced.

The aims of my thesis were to investigate the impact of cancer disease and its treatment on sperm DNA integrity and to study birth outcomes in the offspring of MCS.

In papers 1 and II DFI was investigated in 96 testicular cancer patients (TC) and related to treatment and follow-up time. In paper III sperm DFI was investigated in pretreatment semen from 121 cancer patients in which 58 were analyzed also posttreatment.

Cancer disease per se was associated with a moderate increase in DFI, especially TC and Hodgkin’s lymphoma (mean DFI 17.5 and 16.5% respectively) compared to controls (mean DFI 11.5%), but for the majority of patients DFI was not at levels associated with reduced fertility. In TC patients adjuvant RT induced a transient increase in DFI, normalizing within 3-5 years, whereas intense CT induced a persisting decrease in DFI, DFIpost 9.1 vs. DFIpre 12% (median values, p = 0.02). In paper III, in a group with varying diagnoses, the analysis of cryopreserved pre- vs. posttreatment semen demonstrated no change in DFI, regardless of therapy (median follow-up 3 years).

Study IV was a Danish-Swedish register study investigating the impact of paternal cancer and mode of conception on birth outcomes, including 1.8 million singleton children, born 1994-2005. A moderate increase in malformation rate, 3.7 %, was seen in the 8879 children fathered by MCS, with a RR of 1.17 (95% CI 1.05, 1.31) compared to non-MCS, of having an infant with a malformation. IVF/ICSI was associated with an equivalent increased malformation rate, but did not constitute an additional risk for MCS. Treatment data was not available, but analyses of specific diagnoses, in which treatment can be anticipated, did not indicate that the increased malformation rate was treatment-induced. (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • Professor Hovatta, Outi, Dept of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm
organization
publishing date
type
Thesis
publication status
published
subject
keywords
SCSA, birth outcomes, sperm DNA integrity, male cancer, fertility
in
Lund University, Faculty of Medicine Doctoral Dissertation Series
volume
2008:121
pages
138 pages
defense location
Jubileumsaulan, entrance 59, Malmö University Hospital
defense date
2008-12-12 13:00
ISSN
1652-8220
language
English
LU publication?
yes
id
25f9d2eb-a260-4a23-9faf-e77c41c47e57 (old id 1268572)
date added to LUP
2008-11-19 13:55:46
date last changed
2016-09-19 08:44:59
@misc{25f9d2eb-a260-4a23-9faf-e77c41c47e57,
  abstract     = {Male cancer survivors (MCS) are at risk of suffering from impaired fertility. Male fertility is dependant on sperm DNA quality. The Sperm Chromatin Structure Assay (SCSA) reflects the proportion of sperm with poor DNA, the DNA fragmentation index, DFI. A high DFI indicates reduced in vivo fertility and the need of ICSI (Intracytoplasmic sperm injection) to achieve pregnancy. A concern with ICSI, in which a single spermatozoon is injected into the oocyte, is the risk of transmitting defect DNA to the offspring. For MCS, due to the potential mutagenicity of radiotherapy (RT) and chemotherapy (CT), demonstrated in animal studies, this concern is even more pronounced.<br/><br>
The aims of my thesis were to investigate the impact of cancer disease and its treatment on sperm DNA integrity and to study birth outcomes in the offspring of MCS.<br/><br>
In papers 1 and II DFI was investigated in 96 testicular cancer patients (TC) and related to treatment and follow-up time. In paper III sperm DFI was investigated in pretreatment semen from 121 cancer patients in which 58 were analyzed also posttreatment.<br/><br>
Cancer disease per se was associated with a moderate increase in DFI, especially TC and Hodgkin’s lymphoma (mean DFI 17.5 and 16.5% respectively) compared to controls (mean DFI 11.5%), but for the majority of patients DFI was not at levels associated with reduced fertility. In TC patients adjuvant RT induced a transient increase in DFI, normalizing within 3-5 years, whereas intense CT induced a persisting decrease in DFI, DFIpost 9.1 vs. DFIpre 12% (median values, p = 0.02). In paper III, in a group with varying diagnoses, the analysis of cryopreserved pre- vs. posttreatment semen demonstrated no change in DFI, regardless of therapy (median follow-up 3 years).<br/><br>
Study IV was a Danish-Swedish register study investigating the impact of paternal cancer and mode of conception on birth outcomes, including 1.8 million singleton children, born 1994-2005. A moderate increase in malformation rate, 3.7 %, was seen in the 8879 children fathered by MCS, with a RR of 1.17 (95% CI 1.05, 1.31) compared to non-MCS, of having an infant with a malformation. IVF/ICSI was associated with an equivalent increased malformation rate, but did not constitute an additional risk for MCS. Treatment data was not available, but analyses of specific diagnoses, in which treatment can be anticipated, did not indicate that the increased malformation rate was treatment-induced.},
  author       = {Ståhl, Olof},
  issn         = {1652-8220},
  keyword      = {SCSA,birth outcomes,sperm DNA integrity,male cancer,fertility},
  language     = {eng},
  pages        = {138},
  series       = {Lund University, Faculty of Medicine Doctoral Dissertation Series},
  title        = {Cancer and male reproductive function- the effect on sperm DNA integrity and on birth outcomes in the offspring},
  volume       = {2008:121},
  year         = {2008},
}